Article
Biology
George Nicolae Daniel Ion, George Mihai Nitulescu, Dragos Paul Mihai
Summary: PIM-1 kinase has implications in multiple types of malignancies. Developing better search methodologies for inhibitors and using post-processing docking results can improve drug discovery success rates.
Article
Biochemistry & Molecular Biology
Bruno Oyallon, Marie Brachet-Botineau, Cedric Loge, Thomas Robert, Stephane Bach, Sajida Ibrahim, William Raoul, Cecile Croix, Pascal Berthelot, Jean Guillon, Noel Pinaud, Fabrice Gouilleux, Marie-Claude Viaud-Massuard, Caroline Denevault-Sabourin
Summary: New quinoxaline derivatives acting as dual Pim1/2 inhibitors showed potent inhibition of Pim-1 and Pim-2 enzymes in vitro, and were able to inhibit the growth of multiple myeloma and colorectal carcinoma cell lines expressing high levels of Pim-1/2 kinases.
Article
Biochemistry & Molecular Biology
Mostafa M. M. El-Miligy, Marwa E. Abdelaziz, Salwa M. Fahmy, Tamer M. Ibrahim, Marwa M. Abu-Serie, Mona A. Mahran, Aly A. Hazzaa
Summary: New quinoline-pyridine hybrids were synthesized as PIM-1/2 kinase inhibitors. Several compounds showed low cytotoxicity against normal cells and potent anticancer activity against different cancer cell lines. Some compounds induced apoptosis and caspase activation in specific cancer cell lines. Furthermore, these compounds showed inhibitory activity against PIM-1/2 kinases, with different modes of inhibition. Molecular docking studies confirmed the in vitro inhibitory activities.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
(2023)
Article
Cell & Tissue Engineering
Xin Zhao, Jian Shen, Xuan Zhao, Miao Zhang, Xiao Feng, Weiyu Zhang, Xinyi Lu
Summary: The study uncovers a novel axis by which PIM3 suppresses the 2-cell marker MuERVL and totipotent state in ESCs, and identifies AMPK as the key target regulated by PIM3.
Article
Biochemistry & Molecular Biology
Viet Hung Dao, Isabelle Ourliac-Garnier, Cedric Loge, Florence O. McCarthy, Stephane Bach, Teresinha Goncalves da Silva, Caroline Denevault-Sabourin, Jerome Thiefaine, Blandine Baratte, Thomas Robert, Fabrice Gouilleux, Marie Brachet-Botineau, Marc-Antoine Bazin, Pascal Marchand
Summary: Pim kinases are important targets for anti-tumor therapy, and dibenzo[b,d]furan derivatives show promising inhibitory effects. Lead compound 44 exhibits potent inhibition against Pim-1/2 kinases and CLK1, with low micromolar anticancer potency against the AML cell line MV4-11.
Article
Chemistry, Medicinal
Anne-Sophie Castanet, Mohamed S. Nafie, Sara A. Said, Reem K. Arafa
Summary: This research focuses on the design and synthesis of a new PIM-1 kinase targeting compound, and investigates its potential as an anti-cancer agent through in vitro and in vivo studies. The results demonstrate that compound 10f exhibits strong cytotoxicity against prostate cancer cells, inhibits PIM-1 kinase activity, and has antioxidant and apoptosis-inducing effects. Moreover, 10f shows significant anti-tumor activity in a mouse model. Therefore, compound 10f holds promise as a lead compound for prostate cancer treatment.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2023)
Article
Pharmacology & Pharmacy
Yuichi Sawaguchi, Ryuta Yamazaki, Yukiko Nishiyama, Masayuki Mae, Atsuhiro Abe, Hiroyuki Nishiyama, Fukiko Nishisaka, Tatsuya Ibuki, Toshio Sasai, Takeshi Matsuzaki
Summary: The study investigated novel pan-Pim kinase inhibitors with imidazopyridazine and thiazolidinedione structure, which showed high inhibitory activities against Pim kinases in various cancer cell lines. The compounds suppressed Pim kinase substrate phosphorylation, induced cell cycle arrest at the G1 phase, and triggered apoptosis in cultured cancer cells. In tumor xenograft models, the compounds exhibited antitumor activities, suggesting potential as effective inhibitors for various types of cancer cells.
FRONTIERS IN PHARMACOLOGY
(2021)
Review
Cell Biology
Amber N. Clements, Noel A. Warfel
Summary: This review discusses the role of PIM kinases in tumor development and immune evasion, and explores the potential of using PIM inhibitors in combination with immunotherapy.
Article
Biochemistry & Molecular Biology
Aanchal Rathi, Dhiraj Kumar, Gulam Mustafa Hasan, Mohammad Mahfuzul Haque, Md Imtaiyaz Hassan
Summary: This review article focuses on the physiological significance of PIM kinases in disease progression and therapeutic targeting, as well as predicting functional partners of PIM kinases and mapping their interaction network in cellular physiology of different cancers. The study also provides insight into the mechanism of inhibition and implication of designed inhibitors towards therapeutic management of prostate, breast and other cancers.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
(2021)
Review
Biochemistry & Molecular Biology
Sophie Nock, Eima Karim, Amanda J. Unsworth
Summary: Pim kinases are constitutively active serine/threonine kinases that play important roles in cell survival, proliferation, and migration. They have been primarily studied in cancer progression, but recent research indicates their involvement in cardiovascular diseases as well. Pim kinases are widely expressed in cardiovascular tissues and upregulated in various co-morbidities/risk factors for cardiovascular disease. Therefore, targeting Pim kinases may be beneficial for the prevention and treatment of cardiovascular events in high-risk individuals.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Mostafa M. M. El-Miligy, Ahmed K. Al-Kubeisi, Saad R. El-Zemity, Rasha A. Nassra, Marwa M. Abu-Serie, Aly A. Hazzaa
Summary: The study aimed to combat CRC by synthesizing and evaluating new thymol - 4-thiazolidinone hybrids as multitarget anticancer agents that could inhibit the key COX-2, 5-LOX and PIM-1 kinase enzymes simultaneously. Compound 5g showed the most promising results, inhibiting three key targets leading to inhibition of human CRC cell proliferation both in vitro and in vivo.
BIOORGANIC CHEMISTRY
(2021)
Article
Chemistry, Medicinal
Chufeng Zhang, Wenyan Qi, Yong Li, Minghai Tang, Tao Yang, Kongjun Liu, Yong Chen, Dexin Deng, Mingli Xiang, Lijuan Chen
Summary: The study introduces a novel TYK2 inhibitor, compound 14l, which exhibits potent inhibition and selectivity, and shows potential efficacy in the treatment of immune-mediated diseases.
JOURNAL OF MEDICINAL CHEMISTRY
(2021)
Article
Chemistry, Medicinal
Etienne Auvert, Reidun Aesoy, Francis Giraud, Lars Herfindal, Fabrice Anizon, Pascale Moreau
Summary: By selectively substituting the 1-position, we synthesized a series of new analogues and studied their effects on Pim-1 kinase inhibition and cytotoxicity against AML MOLM-13 cells.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2022)
Article
Chemistry, Medicinal
Lukas Heyder, Phil M. M. Hochban, Corey Taylor, Florent Chevillard, Christof Siefker, Christian Iking, Hannes Borchardt, Achim Aigner, Gerhard Klebe, Andreas Heine, Peter Kolb, Wibke E. Diederich
Summary: In this study, fragment-sized hits binding to Pim-1 kinase were optimized using a combination of computational, synthetic, and crystallographic expertise. The resulting potent ligands target rarely-targeted regions of Pim-1 kinase with affinities in the nanomolar range. The combination of computational and experimental approaches successfully developed a novel molecular scaffold for inhibition of Pim-1 kinase, targeting specific surface regions that have been less frequently investigated.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2023)
Article
Pharmacology & Pharmacy
Patrycja Winska, Monika Wielechowska, Miroslawa Koronkiewicz, Pawel Borowiecki
Summary: CK2 and PIM-1 are serine/threonine kinases involved in essential processes, and inhibiting their activity can reduce cancer cell viability. A series of novel inhibitors were designed and synthesized, and their effects on cancer cells were evaluated. The most active compound demonstrated high selectivity and proapoptotic properties, as well as induction of autophagy.
Article
Chemistry, Medicinal
Michael Friedman, Kristine E. Frank, Ana Aguirre, Maria A. Argiriadi, Heather Davis, Jeremy J. Edmunds, Dawn M. George, Jonathan S. George, Eric Goedken, Bryan Fiamengo, Deborah Hyland, Bin Li, Anwar Murtaza, Michael Morytko, Gagandeep Somal, Kent Stewart, Edit Tarcsa, Stacy Van Epps, Jeffrey Voss, Lu Wang, Kevin Woller, Neil Wishart
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2015)
Article
Chemistry, Medicinal
John T. Randolph, A. Chris Krueger, Pamela L. Donner, John K. Pratt, Dachun Liu, Christopher E. Motter, Todd W. Rockway, Michael D. Tufano, Rolf Wagner, Hock B. Lim, Jill M. Beyer, Rubina Mondal, Neeta S. Panchal, Lynn Colletti, Yaya Liu, Gennadiy Koev, Warren M. Kati, Lisa E. Hernandez, David W. A. Beno, Kenton L. Longenecker, Kent D. Stewart, Emily O. Dumas, Akhteruzzaman Molla, Clarence J. Maring
JOURNAL OF MEDICINAL CHEMISTRY
(2018)
Article
Chemistry, Medicinal
Kent D. Stewart, Jeffrey R. Huth, Teresa I. Ng, Keith McDaniel, Rebecca Newlin Hutchinson, Vincent S. Stoll, Renaldo R. Mendoza, Edmund D. Matayoshi, Robert Carrick, HongMei Mo, Jean Severin, Karl Walter, Paul L. Richardson, Leo W. Barrett, Robert Meadows, Steve Anderson, William Kohlbrenner, Clarence Maring, Dale J. Kempf, Akhter Molla, Edward T. Olejniczak
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2010)
Article
Chemistry, Medicinal
Steve D. Fidanze, Scott A. Erickson, Gary T. Wang, Robert Mantei, Richard F. Clark, Bryan K. Sorensen, Nwe Y. Bamaung, Peter Kovar, Eric F. Johnson, Kerren K. Swinger, Kent D. Stewart, Qian Zhang, Lora A. Tucker, William N. Pappano, Julie L. Wilsbacher, Jieyi Wang, George S. Sheppard, Randy L. Bell, Steven K. Davidsen, Robert D. Hubbard
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2010)
Article
Chemistry, Medicinal
Douglas K. Hutchinson, Charles A. Flentge, Pamela L. Donner, Rolf Wagner, Clarence J. Maring, Warren M. Kati, Yaya Liu, Sherie V. Masse, Tim Middleton, Hongmei Mo, Debra Montgomery, Wen W. Jiang, Gennadiy Koev, David W. A. Beno, Kent D. Stewart, Vincent S. Stoll, Akhteruzzaman Molla, Dale J. Kempf
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2011)
Article
Chemistry, Medicinal
William J. McClellan, Yujia Dai, Cele Abad-Zapatero, Daniel H. Albert, Jennifer J. Bouska, Keith B. Glaser, Terry J. Magoc, Patrick A. Marcotte, Donald J. Osterling, Kent D. Stewart, Steven K. Davidsen, Michael R. Michaelides
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2011)
Article
Chemistry, Medicinal
Zhiqin Ji, Yujia Dai, Cele Abad-Zapatero, Daniel H. Albert, Jennifer J. Bouska, Keith B. Glaser, Patrick A. Marcotte, Nirupama B. Soni, Terry J. Magoc, Kent D. Stewart, Ru-Qi Wei, Steve K. Davidsen, Michael R. Michaelides
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2012)
Article
Chemistry, Medicinal
Michael L. Curtin, H. Robin Heyman, Robin R. Frey, Patrick A. Marcotte, Keith B. Glaser, James R. Jankowski, Terrance J. Magoc, Daniel H. Albert, Amanda M. Olson, David R. Reuter, Jennifer J. Bouska, Debra A. Montgomery, Joann P. Palma, Cherrie K. Donawho, Kent D. Stewart, Chris Tse, Michael R. Michaelides
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2012)
Article
Chemistry, Medicinal
Qingwei Zhang, Zhiren Xia, Michael J. Mitten, Loren M. Lasko, Vered Klinghofer, Jennifer Bouska, Eric F. Johnson, Thomas D. Penning, Yan Luo, Vincent L. Giranda, Alexander R. Shoemaker, Kent D. Stewart, Stevan W. Djuric, Anil Vasudevan
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2012)
Article
Chemistry, Medicinal
Anil Vasudevan, Mary K. Verzal, Clara I. Villamil, Kent D. Stewart, Cele Abad-Zapatero, Tetsuro Oie, Stevan W. Djuric
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2012)
Article
Chemistry, Medicinal
Michael L. Curtin, Robin R. Frey, H. Robin Heyman, Niru B. Soni, Patrick A. Marcotte, Lori J. Pease, Keith B. Glaser, Terrance J. Magoc, Paul Tapang, Daniel H. Albert, Donald J. Osterling, Amanda M. Olson, Jennifer J. Bouska, Zhiwen Guan, Lee C. Preusser, James S. Polakowski, Kent D. Stewart, Chris Tse, Steven K. Davidsen, Michael R. Michaelides
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2012)
Article
Chemistry, Medicinal
Stacy Van Epps, Bryan Fiamengo, Jeremy Edmunds, Anna Ericsson, Kristine Frank, Michael Friedman, Dawn George, Jonathan George, Eric Goedken, Brian Kotecki, Gloria Martinez, Philip Merta, Michael Morytko, Shashank Shekhar, Barbara Skinner, Kent Stewart, Jeffrey Voss, Grier Wallace, Lu Wang, Lu Wang, Neil Wishart
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2013)
Article
Chemistry, Medicinal
A. Chris Krueger, John T. Randolph, David A. DeGoey, Pamela L. Donner, Charles A. Flentge, Douglas K. Hutchinson, Dachun Liu, Christopher E. Motter, Todd W. Rockway, Rolf Wagner, David W. A. Beno, Gennadiy Koev, Hock B. Lim, Jill M. Beyer, Rubina Mondal, Yaya Liu, Warren M. Kati, Kenton L. Longenecker, Akhteruzzaman Molla, Kent D. Stewart, Clarence J. Maring
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2013)
Article
Chemistry, Medicinal
Steven W. Muchmore, Jeremy J. Edmunds, Kent D. Stewart, Philip J. Hajduk
JOURNAL OF MEDICINAL CHEMISTRY
(2010)
Article
Chemistry, Medicinal
Yunsong Tong, Kent D. Stewart, Alan S. Florjancic, John E. Harlan, Philip J. Merta, Magdalena Przytulinska, Nirupama Soni, Kerren K. Swinger, Haizhong Zhu, Eric F. Johnson, Alexander R. Shoemaker, Thomas D. Penning
ACS MEDICINAL CHEMISTRY LETTERS
(2013)
Article
Chemistry, Medicinal
Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan
Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang
Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman
Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li
Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang
Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla
Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)